BIOPHARMA

'Biopharma' is a >$1 trillion/year industry using the now predominant broad definition; and is a >$400 billion/year subset using the classic definition. In the next few years, the 'Pharma(ceutical)' industry will genuinely become the 'Biopharma(ceutical)' industry as biopharmaceutical (using the classic biotech-grounded defintion) R&D and product revenue top that of chemically-derived/synthetic pharmaceuticals. With this, 'biopharma(ceutical)' will come to fully replace 'pharma(ceutical)' in common usage; surely assisted by the global pharmaceutical industry, long publicly claiming to be 'biopharmaceutical.'... BIOPHARMA®: U.S. trademark for "providing information in the fields of biopharmaceuticals via electronic databases, Web sites and the Internet;" the only BIOPHARMA® trademark... 2) in the past decade with push from industry, "biopharma(ceutical)" has become (or soon enough will be) the preferred popular/common and industry's-own term for the global pharmaceutical industry and..

Primary location: Rockville United States